BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31025131)

  • 41. Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database.
    Lally BE; Geiger AM; Urbanic JJ; Butler JM; Wentworth S; Perry MC; Wilson LD; Horton JK; Detterbeck FC; Miller AA; Thomas CR; Blackstock AW
    Lung Cancer; 2009 May; 64(2):226-31. PubMed ID: 18835059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small cell lung cancer: time to diagnosis and treatment.
    Haque N; Raza A; McGoey R; Boulmay B; Diethelm L; Kantrow S
    South Med J; 2012 Aug; 105(8):418-23. PubMed ID: 22864099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival following Multimodality Treatment Including Surgery for Stage IA-IIIB Small-Cell Lung Cancer.
    Weckler BC; Baldes N; Schirren J
    Thorac Cardiovasc Surg; 2019 Jun; 67(4):291-298. PubMed ID: 30092600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic significance of serum soluble DR5 levels in small-cell lung cancer.
    Wan Z; Zhang X; Yu X; Hou Y
    Int J Med Sci; 2019; 16(3):403-408. PubMed ID: 30911274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
    Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
    Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
    Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
    Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
    Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
    Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Small cell lung cancer in the young: Characteristics, diagnosis and outcome data.
    Jiang S; Hao X; Li J; Hu X; Xiao Z; Wang H; Wang Y; Sun Y; Shi Y
    Clin Respir J; 2019 Feb; 13(2):98-104. PubMed ID: 30586232
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.
    Misch D; Blum T; Boch C; Weiss T; Crolow C; Griff S; Mairinger T; Bauer TT; Kollmeier J
    Diagn Pathol; 2015 Apr; 10():21. PubMed ID: 25889870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors associated with delayed treatment initiation in an unselected cohort of patients with small-cell lung cancer.
    Laerum D; Brustugun OT; Gallefoss F; Falk R; Strand TE; Fjellbirkeland L
    Cancer Treat Res Commun; 2021; 29():100477. PubMed ID: 34700140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer.
    Käsmann L; Bolm L; Janssen S; Rades D
    Anticancer Res; 2017 Mar; 37(3):1535-1537. PubMed ID: 28314330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.
    Kesarwala AH; Lu DJ; Xanthopoulos E; Apisarnthanarax S; Cengel KA; Evans TL; Aggarwal C; Cohen RB; Langer CJ; Rengan R; Simone CB
    Clin Lung Cancer; 2018 Mar; 19(2):e205-e209. PubMed ID: 29153967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
    Sas-Korczynska B; Sokolowski A; Korzeniowski S
    Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
    Zhou M; Wang Z; Yao Y; Zhou H; Liu M; Sun J
    Clin Transl Oncol; 2017 Jul; 19(7):865-873. PubMed ID: 28127669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung cancer in Victoria: are we making progress?
    Mitchell PL; Thursfield VJ; Ball DL; Richardson GE; Irving LB; Torn-Broers Y; Giles GG; Wright GM
    Med J Aust; 2013 Nov; 199(10):674-9. PubMed ID: 24237097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma.
    Terashima T; Morizane C; Hiraoka N; Tsuda H; Tamura T; Shimada Y; Kaneko S; Kushima R; Ueno H; Kondo S; Ikeda M; Okusaka T
    Neuroendocrinology; 2012; 96(4):324-32. PubMed ID: 22572060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of care for people with small cell lung cancer in Victoria, 2011-19: a retrospective, population-based registry data study.
    Huang J; Faisal W; Brand M; Smith S; Alexander M; Briggs L; Conron M; Duffy M; John T; Langton D; Lesage J; MacManus M; Mitchell P; Olesen I; Parente P; Philip J; Samuel E; Torres J; Underhill CR; Zalcberg JR; Harden S; Stirling R
    Med J Aust; 2023 Aug; 219(3):120-126. PubMed ID: 37365486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response.
    Fujii M; Hotta K; Takigawa N; Hisamoto A; Ichihara E; Tabata M; Tanimoto M; Kiura K
    Lung Cancer; 2012 Oct; 78(1):107-11. PubMed ID: 22858447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.